Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 28Stomach Neoplasms 21Pancreatic Neoplasms 14Colonic Neoplasms 14Rectal Neoplasms 9Esophageal Neoplasms 8Lymphoma, Large B-Cell, Diffuse 7Adenocarcinoma Of Esophagus 7Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Cholangiocarcinoma 4Adenocarcinoma 4Ovarian Neoplasms 3Neoplasm Metastasis 3Esophageal Squamous Cell Carcinoma 3Squamous Cell Carcinoma of Head and Neck 2Lymphoma, Follicular 2Hepatoblastoma 2Gastrointestinal Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Hepatocellular 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unresectable Colorectal Cancer 1Triple Negative Breast Neoplasms 1Spinocerebellar Degenerations 1Solid Cancer 1Skin Neoplasms 1Recurrence 1

Interventions

dehydroftorafur 1atezolizumab 1Specimen Handling 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × DNA Repair-Deficiency Disorders × Oxaliplatin × Clear all
NCT02912559 2026-06-01

Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

National Cancer Institute (NCI)

Phase 3 Active not recruiting
712 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, DNA Repair-Deficiency Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡